Track topics on Twitter Track topics that are important to you
Triumvira Immunologics, an Austin, TX-based biotech, appointed Donna Rill to serve as chief technology officer. Triumvera said Rill will use her technology development and manufacturing experience to ...
The University of Toronto granted Triumvira Immunologics Inc. exclusive rights to antibodies for use in the development of T-cell therapeutics for cancer.
Innovative immuno-therapy company welcomes former President and COO of Celgene Triumvira Immunologics, Inc., a privately held biopharmaceutical company developin...
Triumvira Immunologics, Inc. (Triumvira), announced the upcoming presentation of key preclinical data at the American Society of Hematology (ASH) 60th Annual Meeting and Expositio...
Brings 30-years of Experience to Company’s Technology Development and Manufacturing Operations Triumvira Immunologics, a privately held biopharmaceutical company deve...
The Centre for the Commercialization of Antibodies and Biologics (CCAB) and Triumvira Immunologics, Inc. (Triumvira), announced today a new licensing agreement between the
New Preclinical Data Presented at Annual Meeting of American Society of Hematology Triumvira Immunologics Inc. (Triumvira), announced the presentation of key preclinica...
TAC technology shows efficacy, safety, and TAC-T cell persistence in preclinical models of liquid and solid tumors Triumvira Immunologics, Inc. (Triumvira), a privately...
Triumvira Immunologics, Inc. (âTriumviraâ) is an immunotherapy company co-founded in 2015 by Dr. Jonathan Bramson at McMaster University and Bloom Burton & Co., with the...
Triumvira Immunologics, Inc. is an immunotherapy company co-founded in 2015 by Dr. Jonathan Bramson at McMaster University and Bloom Burton & Co., a niche life-sciences investment...
Triumvira is developing an engineered T-cell technology called the T-Cell Antigen Coupler (TAC), developed in the laboratory of Dr. Jonathan Bramson at McMaster University in Hami...
Signature Immunologics produces anti-hapten IgGs for High Performance Immunocytochemistry (HPI), targeting key small molecules in cell physiology, including fast neurotransmitter amino acids and pivot...
We have published hundreds of Triumvira Immunologics news stories on BioPortfolio along with dozens of Triumvira Immunologics Clinical Trials and PubMed Articles about Triumvira Immunologics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Triumvira Immunologics Companies in our database. You can also find out about relevant Triumvira Immunologics Drugs and Medications on this site too.